AntriaBio Inc Stock OTC Bulletin Board
Equities
US0372301095
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
05-22 | Traders Cautious Ahead of Fed Minutes, Nvidia Earnings, Stifling US Equity Futures Pre-Bell | MT |
05-22 | Top Premarket Gainers | MT |
Sales 2024 * | - | Sales 2025 * | 23.49M 32M | Capitalization | 162M 220M |
---|---|---|---|---|---|
Net income 2024 * | -63M -85.84M | Net income 2025 * | -49M -66.77M | EV / Sales 2024 * | - |
Net cash position 2024 * | 86M 117M | Net cash position 2025 * | 68M 92.66M | EV / Sales 2025 * | 3.99 x |
P/E ratio 2024 * |
-3.44
x | P/E ratio 2025 * |
-5.14
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.6% |
Latest transcript on AntriaBio Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 10-07-25 | |
Nevan Elam
CEO | Chief Executive Officer | 56 | 10-07-25 |
Daron Evans
DFI | Director of Finance/CFO | 50 | 01-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nevan Elam
CEO | Chief Executive Officer | 56 | 10-07-25 |
Young-Jin Kim
BRD | Director/Board Member | 67 | 19-02-09 |
Gil Labrucherie
BRD | Director/Board Member | 52 | 19-11-19 |
1st Jan change | Capi. | |
---|---|---|
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |